Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17476601 | 1.00 | ALDH1A1 (0.45) | ALDH1A1CXCR4SMN1; SMN2 | |
| SCHEMBL29774713 | 0.90 | ALDH1A1 (0.45) | ALDH1A1CXCR4SMN1; SMN2 | |
| SCHEMBL5771150 | 0.90 | — | — | |
| SCHEMBL16583982 | 0.85 | ALDH1A1 (0.45) | ALDH1A1CXCR4SMN1; SMN2 | |
| SCHEMBL21880823 | 0.85 | ALDH1A1 (0.45) | ALDH1A1CXCR4SMN1; SMN2 | |
| SCHEMBL15523093 | 0.84 | — | — | |
| SCHEMBL15523094 | 0.84 | — | — | |
| SCHEMBL5008482 | 0.82 | CXCR4 (0.40) | ALDH1A1CXCR4SMN1; SMN2 | |
| SCHEMBL9457374 | 0.82 | CXCR4 (0.40) | ALDH1A1CXCR4SMN1; SMN2 | |
| SCHEMBL16100464 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119799151-A | Polyurethane coating for road marking and preparation method thereof | 万华化学集团股份有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118496801-A | Single-component polyurethane glass cement and preparation method and application thereof | 湖北回天新材料股份有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118184895-A | Preparation method and application of polyurethane resin | 南京聚发新材料有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-115572365-B | Preparation method and application of crosslinkable polyurethane coating | 合肥安利聚氨酯新材料有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117263988-A | Method for preparing tetravalent platinum medicine from hydroxyl-containing organic matter, tetravalent platinum medicine and application of tetravalent platinum medicine | 深圳大学 | 2023-12-22 | — | — | CN | claimed |
| CN-114539504-B | High-fluidity pipeline heat-insulating material and preparation method thereof | 万华化学集团股份有限公司 | 2023-05-26 | — | — | CN | claimed |
| CN-116063975-A | Polyurethane adhesive and preparation and application thereof | 浙江华峰合成树脂有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-115572365-A | Preparation method and application of crosslinkable polyurethane coating | 合肥安利聚氨酯新材料有限公司 | 2023-01-06 | — | — | CN | claimed |
| CN-112388794-B | Aldehyde-free light shaving board and preparation method thereof | 万华化学集团股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-111808263-B | Preparation method of polyurethane composition for shoes and formed body thereof | 浙江华峰新材料有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114539504-A | High-fluidity pipeline thermal insulation material and preparation method thereof | 万华化学集团股份有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-111647125-B | Polyurethane composition and preparation of sponge product thereof | 浙江华峰新材料有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-107674106-B | Preparation method of obeticholic acid dimer | 华北制药集团新药研究开发有限责任公司 | 2021-06-22 | — | — | CN | claimed |
| CN-111808263-A | Preparation method of polyurethane composition for shoes and formed body thereof | 浙江华峰新材料有限公司 | 2020-10-23 | — | — | CN | claimed |
| CN-111647125-A | Polyurethane composition and preparation of sponge product thereof | 浙江华峰新材料有限公司 | 2020-09-11 | — | — | CN | claimed |
| CN-111138492-A | Preparation method of ALK inhibitor brigatinib | 沈阳药科大学 | 2020-05-12 | — | — | CN | claimed |
| US-20170217896-A1 | Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs | BRISTOL-MYERS SQUIBB COMPANY | 2017-08-03 | — | — | US | claimed |
| EP-3174854-A1 | METHOD OF PREPARING FLUORINE-18 LABELED CABOZANTINIB AND ITS ANALOGS | Exelixis, Inc. (US) | 2017-06-07 | — | — | EP | claimed |
| WO-2016019285-A1 | METHOD OF PREPARING FLUORINE-18 LABELED CABOZANTINIB AND ITS ANALOGS | EXELIXIS, INC. (US) | 2016-02-04 | — | — | WO | claimed |
| US-4636574-A | Process for preparing arylisothiocyanates | ETHYL CORPORATION (US) | 1987-01-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217896-A1 | Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs | FGFR1, PDGFRA, KIF18B | ALDH1A1 961/4885CXCR4 159/4885SMN1; SMN2 3933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.